Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,713JPY
21 Sep 2018
Change (% chg)

¥0 (+0.00%)
Prev Close
¥4,713
Open
¥4,715
Day's High
¥4,734
Day's Low
¥4,683
Volume
5,761,400
Avg. Vol
4,240,939
52-wk High
¥6,693
52-wk Low
¥4,203

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 410,578.00 411,156.00 410,000.00 --
Year Ending Mar-18 11 1,771,210.00 1,809,940.00 1,723,500.00 --
Year Ending Mar-19 9 1,761,570.00 1,790,000.00 1,722,000.00 1,749,610.00
Year Ending Mar-20 8 1,813,060.00 1,892,910.00 1,771,000.00 1,819,860.00
Earnings (per share)
Quarter Ending Mar-18 2 -71.44 -60.20 -82.68 --
Year Ending Mar-18 11 216.49 248.40 200.50 --
Year Ending Mar-19 9 206.84 340.67 122.76 184.90
Year Ending Mar-20 9 246.39 405.91 193.40 212.18
LT Growth Rate (%) 1 -1.98 -1.98 -1.98 11.25
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 30.89 30.49 32.71
P/E High - Last 5 Yrs. 50.50 42.04 47.27
P/E Low - Last 5 Yrs. 21.82 23.56 24.80
Beta 0.64 0.90 0.87
Price to Sales (TTM) 2.11 4.35 6.42
Price to Book (MRQ) 1.81 3.53 3.91
Price to Tangible Book (MRQ) -- 5.09 5.97
Price to Cash Flow (TTM) 12.72 22.24 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 3.82 1.83 1.69
Dividend Yield - 5 Year Avg 3.40 1.53 1.45
Dividend 5 Year Growth Rate 0.00 -8.57 -5.70
Payout Ratio(TTM) 118.56 49.39 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.36 5.63 8.45
Sales (TTM) vs TTM 1 Yr. Ago 1.48 4.62 6.71
Sales - 5 Yr. Growth Rate 2.60 6.93 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -46.04 18.71 25.51
EPS (TTM) vs TTM 1 Yr. Ago -25.11 -- --
EPS - 5 Yr. Growth Rate 4.77 6.47 7.60
Capital Spending - 5 Yr. Growth Rate 2.70 7.80 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.12 2.19 2.20
Current Ratio (MRQ) 1.42 2.93 2.97
LT Debt to Equity (MRQ) 48.63 8.94 11.21
Total Debt to Equity (MRQ) 48.69 11.22 14.02
Interest Coverage (TTM) 32.99 41.23 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.03 55.18 54.73
Gross Margin - 5 Yr. Avg. 70.37 53.33 53.30
EBITD Margin (TTM) 18.08 -- --
EBITD - 5 Yr. Avg 20.95 18.71 15.89
Operating Margin (TTM) 8.22 13.37 3.72
Operating Margin - 5 Yr. Avg. 6.03 14.29 11.01
Pre-Tax Margin (TTM) 6.37 13.76 4.04
Pre-Tax Margin - 5 Yr. Avg. 5.63 14.60 11.19
Net Profit Margin (TTM) 6.76 10.38 0.77
Net Profit Margin - 5 Yr. Avg. 4.01 10.89 7.53
Effective Tax Rate (TTM) -6.18 20.48 20.44
Effective Tax Rate - 5 Yr. Avg. 28.77 23.83 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 65,079,880 820,576,740 715,149,750
Net Income/Employee (TTM) 4,399,523 94,890,309 82,590,366
Receivable Turnover (TTM) 3.96 5.00 5.01
Inventory Turnover (TTM) 2.17 2.52 3.61
Asset Turnover (TTM) 0.42 0.83 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 2.82 9.99 9.73
Return on Assets - 5 Yr. Avg. 1.67 11.38 10.90
Return on Investment (TTM) 3.53 13.04 12.72
Return on Investment - 5 Yr. Avg. 2.19 14.69 14.02
Return on Equity (TTM) 5.93 14.98 14.84
Return on Equity - 5 Yr. Avg. 3.24 15.89 15.37
  1 Year 3 Year 5 Year
Sales % 2.22 -0.14 2.60
EPS (TTM) % 62.43 -- 4.77
Dividend % 0.00 0.00 0.00
Note: Units in Millions of US Dollars

Performance for Takeda Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.25 -0.97 99 43
13 Week 4.87 2.70 99 71
26 Week -15.97 -18.80 99 53
52 Week -22.81 -27.98 99 37
YTD -26.37 -25.14 99 42
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 60.68%
# of Holders: 370
Total Shares Held: 482,205,864
3 Mo. Net Change: 49,784,690
# New Positions: 22
# Closed Positions: 19
# Increased Positions: 123
# Reduced Positions: 96
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.